Validation of the Brugia Test Plus to detect IgG4 antibodies in individuals from Belitung Timur, a Brugia malayi endemic area in Indonesia.

The Brugia Test Plus (BT+) is a new rapid diagnostic test for Brugia species which detects human IgG4 antibodies specific for the immunogenic Brugia protein BmR1. The aim of this study was to evaluate the BT+ assay with several types of sample-matrices: whole blood, plasma, and dried blood spots (DB...

Full description

Saved in:
Bibliographic Details
Main Authors: Taniawati Supali, Elisa Iskandar, Noviani Sugianto, Yenny Djuardi, Katherine Gass, Jean M Saunders, Peter U Fischer, Marco A Biamonte
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-08-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0013449
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849228107424202752
author Taniawati Supali
Elisa Iskandar
Noviani Sugianto
Yenny Djuardi
Katherine Gass
Jean M Saunders
Peter U Fischer
Marco A Biamonte
author_facet Taniawati Supali
Elisa Iskandar
Noviani Sugianto
Yenny Djuardi
Katherine Gass
Jean M Saunders
Peter U Fischer
Marco A Biamonte
author_sort Taniawati Supali
collection DOAJ
description The Brugia Test Plus (BT+) is a new rapid diagnostic test for Brugia species which detects human IgG4 antibodies specific for the immunogenic Brugia protein BmR1. The aim of this study was to evaluate the BT+ assay with several types of sample-matrices: whole blood, plasma, and dried blood spots (DBS) from individuals living in Belitung Timur, a Brugia malayi endemic area in Indonesia. Night blood was collected from residents living in four presumed endemic villages, while DBS were collected from schoolchildren living in those four villages. The sensitivity of BT+ was measured by comparing the BT+ results to microscopic examination for microfilaria (Mf). The sensitivity of BT+ with whole blood under field conditions was 84.9% (95% CI 68.1-94.9, n = 33), and with EDTA plasma under laboratory conditions was 95.9% (95% CI 88.5-99.1, n = 73). Specificity was not assessed as it is impossible do so for an antibody test in endemic areas. In Mf-negative individuals, BT+ detected IgG4 antibodies in 204 out of 1,547 adult plasma samples (13.2%) and 7 out of 146 plasma samples collected from children aged 10-16 (4.8%). Detection of IgG4 antibodies in DBS collected from first and second grade schoolchildren (age 6-8) showed that only 1 out of 244 schoolchildren was positive (0.1%). Three individual readers were responsible for reading the BT+ . Statistical analysis showed high agreement among those readers (Kappa agreement value above 0.9). Laboratory technicians found the BT+ is simple to perform, easy to interpret the results, and appreciated the small volume of blood required (5 µL). This study has demonstrated that the novel BT+ is feasible for teams to implement and achieves good sensitivity, making it well suited for monitoring and evaluating the progress of the brugian- filariasis elimination program.
format Article
id doaj-art-b66935fa261444cbbd2bb87d3da33bb5
institution Kabale University
issn 1935-2727
1935-2735
language English
publishDate 2025-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-b66935fa261444cbbd2bb87d3da33bb52025-08-23T05:33:10ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352025-08-01198e001344910.1371/journal.pntd.0013449Validation of the Brugia Test Plus to detect IgG4 antibodies in individuals from Belitung Timur, a Brugia malayi endemic area in Indonesia. Taniawati SupaliElisa IskandarNoviani SugiantoYenny DjuardiKatherine GassJean M SaundersPeter U FischerMarco A BiamonteThe Brugia Test Plus (BT+) is a new rapid diagnostic test for Brugia species which detects human IgG4 antibodies specific for the immunogenic Brugia protein BmR1. The aim of this study was to evaluate the BT+ assay with several types of sample-matrices: whole blood, plasma, and dried blood spots (DBS) from individuals living in Belitung Timur, a Brugia malayi endemic area in Indonesia. Night blood was collected from residents living in four presumed endemic villages, while DBS were collected from schoolchildren living in those four villages. The sensitivity of BT+ was measured by comparing the BT+ results to microscopic examination for microfilaria (Mf). The sensitivity of BT+ with whole blood under field conditions was 84.9% (95% CI 68.1-94.9, n = 33), and with EDTA plasma under laboratory conditions was 95.9% (95% CI 88.5-99.1, n = 73). Specificity was not assessed as it is impossible do so for an antibody test in endemic areas. In Mf-negative individuals, BT+ detected IgG4 antibodies in 204 out of 1,547 adult plasma samples (13.2%) and 7 out of 146 plasma samples collected from children aged 10-16 (4.8%). Detection of IgG4 antibodies in DBS collected from first and second grade schoolchildren (age 6-8) showed that only 1 out of 244 schoolchildren was positive (0.1%). Three individual readers were responsible for reading the BT+ . Statistical analysis showed high agreement among those readers (Kappa agreement value above 0.9). Laboratory technicians found the BT+ is simple to perform, easy to interpret the results, and appreciated the small volume of blood required (5 µL). This study has demonstrated that the novel BT+ is feasible for teams to implement and achieves good sensitivity, making it well suited for monitoring and evaluating the progress of the brugian- filariasis elimination program.https://doi.org/10.1371/journal.pntd.0013449
spellingShingle Taniawati Supali
Elisa Iskandar
Noviani Sugianto
Yenny Djuardi
Katherine Gass
Jean M Saunders
Peter U Fischer
Marco A Biamonte
Validation of the Brugia Test Plus to detect IgG4 antibodies in individuals from Belitung Timur, a Brugia malayi endemic area in Indonesia.
PLoS Neglected Tropical Diseases
title Validation of the Brugia Test Plus to detect IgG4 antibodies in individuals from Belitung Timur, a Brugia malayi endemic area in Indonesia.
title_full Validation of the Brugia Test Plus to detect IgG4 antibodies in individuals from Belitung Timur, a Brugia malayi endemic area in Indonesia.
title_fullStr Validation of the Brugia Test Plus to detect IgG4 antibodies in individuals from Belitung Timur, a Brugia malayi endemic area in Indonesia.
title_full_unstemmed Validation of the Brugia Test Plus to detect IgG4 antibodies in individuals from Belitung Timur, a Brugia malayi endemic area in Indonesia.
title_short Validation of the Brugia Test Plus to detect IgG4 antibodies in individuals from Belitung Timur, a Brugia malayi endemic area in Indonesia.
title_sort validation of the brugia test plus to detect igg4 antibodies in individuals from belitung timur a brugia malayi endemic area in indonesia
url https://doi.org/10.1371/journal.pntd.0013449
work_keys_str_mv AT taniawatisupali validationofthebrugiatestplustodetectigg4antibodiesinindividualsfrombelitungtimurabrugiamalayiendemicareainindonesia
AT elisaiskandar validationofthebrugiatestplustodetectigg4antibodiesinindividualsfrombelitungtimurabrugiamalayiendemicareainindonesia
AT novianisugianto validationofthebrugiatestplustodetectigg4antibodiesinindividualsfrombelitungtimurabrugiamalayiendemicareainindonesia
AT yennydjuardi validationofthebrugiatestplustodetectigg4antibodiesinindividualsfrombelitungtimurabrugiamalayiendemicareainindonesia
AT katherinegass validationofthebrugiatestplustodetectigg4antibodiesinindividualsfrombelitungtimurabrugiamalayiendemicareainindonesia
AT jeanmsaunders validationofthebrugiatestplustodetectigg4antibodiesinindividualsfrombelitungtimurabrugiamalayiendemicareainindonesia
AT peterufischer validationofthebrugiatestplustodetectigg4antibodiesinindividualsfrombelitungtimurabrugiamalayiendemicareainindonesia
AT marcoabiamonte validationofthebrugiatestplustodetectigg4antibodiesinindividualsfrombelitungtimurabrugiamalayiendemicareainindonesia